Navigation Links
MDS Pharma Services Names Rudy Howard Chief Financial Officer
Date:1/7/2009

KING OF PRUSSIA, PA, Jan. 7 /PRNewswire-FirstCall/ - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, today announced the appointment of Rudy Howard as Senior Vice-President and Chief Financial Officer.

Mr. Howard has extensive experience as a senior financial executive in the pharmaceutical and contract research organization (CRO) industry sectors, including six years as CFO at Pharmaceutical Product Development, Inc. He joins MDS Pharma Services from his private consulting practice where he offered business and financial consulting services, including merger and acquisition services, for clients across a variety of industries, including pharmaceutical and biotechnology.

"We are delighted to add someone with Rudy's breadth and depth of skills and expertise to our leadership team at MDS Pharma Services," said MDS Pharma Services President David Spaight. "His impressive portfolio of financial, business development and change management capabilities in the pharmaceutical and contract research industries makes him an excellent choice to lead the MDS Pharma Services finance organization at this time."

Before founding his consulting practice, Mr. Howard was CFO at Peopleclick Inc., a human resources software-development company. Previously, he was a Partner at PricewaterhouseCoopers, where his specialization included financial services, high technology, pharmaceuticals and manufacturing. He began his career in public accounting with Deloitte and Touche LLP.

About MDS Pharma Services

MDS Pharma Services is committed to delivering quality service on-time. We offer a full spectrum of resources to meet the drug-discovery and development needs of the pharmaceutical and biotechnology industries. With numerous facilities strategically located around the world, we apply advanced scientific and technological expertise throughout the drug discovery and development process - from lead optimization, pre-IND research, early clinical research (bioequivalence, phases I-IIa) and bioanalysis through to global clinical development (phases IIb-IV), central lab and centralized cardiac services. For more information, visit our website at www.mdsps.com.

MDS Pharma Services is a business unit of MDS Inc. (TSX: MDS; NYSE: MDZ), a global life-sciences company that provides market-leading products and services that our customers need for the development of drugs and diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS has more than 5,000 highly skilled people in 29 countries. Find out more at www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.


'/>"/>
SOURCE MDS Pharma Services
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. NABP Expanding Computer-Based Test Delivery to Include Foreign Pharmacy Graduate Equivalency Examination(R)
2. MiddleBrook Pharmaceuticals to Launch Moxatag(TM) March 2009
3. M Resort, Spa and Casino to Include On-Property Pharmacy
4. Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company License to Certain Alzheimers Patents and Patent Applications
5. Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference
6. Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO
7. BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent
8. Halo Pharmaceutical, Inc. Acquires Whippany Manufacturing Facility from Abbott
9. Kyp Systems Takes on the Challenge of New Pharmaceutical Marketing Guidelines
10. Akrimax Pharmaceuticals Announces Manufacturing Partnership
11. Prism Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... February 09, 2016 , ... ... officially been won. A team from 21st Century Medicine (21CM) ( http://www.21cm.com/ ... preserve the delicate neural circuits of an intact rabbit brain for extremely long-term ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... Nutrition into the Food & Beverage and Dietary Supplement ... partner throughout Canada and USA geographies east of the Rocky Mountains since 2012. ...
(Date:2/8/2016)... ... ... famous for gift giving with flowers, chocolates and other tokens of affection meant to remind ... than 5.6 million Americans suffering with Alzheimer’s, those store bought gifts - no matter ... they’ve led and the people they’ve touched. , That’s why Give To ...
(Date:2/8/2016)... , ... February 08, 2016 , ... If you are ... to handle, you are not alone. According to the Center for Disease Control and ... stroke, type 2 diabetes and certain types of cancer, some of the leading causes ...
(Date:2/8/2016)... IN (PRWEB) , ... February 08, 2016 , ... ... the Indianapolis, IN metro area, has selected the latest beneficiary of their ongoing ... organization dedicated to preventing bullying in area schools. Donations are now being accepted ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... Mast Therapeutics, Inc. (NYSE MKT: MSTX), ... disease and heart failure, today announced that it intends to ... stock in an underwritten public offering.  The offering is subject ... assurance as to whether or when the offering may be ... the offering.   --> --> ...
(Date:2/9/2016)... 9, 2016 The new report "Global Diagnostic Ultrasound Devices ... Consulting group reveals that global diagnostic ultrasound devices market was valued ... US$ 7,466.3 million by 2019 at a CAGR of 6.8% from ... ultrasound market has been analyzed for six geographies of ... Asia-Pacific , Latin America , ...
(Date:2/9/2016)... , Feb. 9, 2016 The leader ... that AcceleDent ® is the recipient of the ... category. An FDA-cleared, Class II medical device that speeds ... percent and relieves pain often associated with treatment, AcceleDent ... participated in the annual Orthotown survey of ...
Breaking Medicine Technology: